121 related articles for article (PubMed ID: 10867335)
1. Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation.
Densem CG; Hutchinson IV; Cooper A; Yonan N; Brooks NH
J Heart Lung Transplant; 2000 Jun; 19(6):551-6. PubMed ID: 10867335
[TBL] [Abstract][Full Text] [Related]
2. Donor and recipient-transforming growth factor-beta 1 polymorphism and cardiac transplant-related coronary artery disease.
Densem CG; Hutchinson IV; Yonan N; Brooks NH
Transpl Immunol; 2004 Nov; 13(3):211-7. PubMed ID: 15381204
[TBL] [Abstract][Full Text] [Related]
3. A novel polymorphism of the gene encoding furin, a TGF-beta1 activator, and the influence on cardiac allograft vasculopathy formation.
Densem CG; Mutlak AS; Pravica V; Brooks NH; Yonan N; Hutchinson IV
Transpl Immunol; 2004 Nov; 13(3):185-90. PubMed ID: 15381201
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta in relation to cardiac allograft vasculopathy after heart transplantation.
Aziz T; Hasleton P; Hann AW; Yonan N; Deiraniya A; Hutchinson IV
J Thorac Cardiovasc Surg; 2000 Apr; 119(4 Pt 1):700-8. PubMed ID: 10733758
[TBL] [Abstract][Full Text] [Related]
5. Influence of tumor necrosis factor-alpha gene-308 polymorphism on the development of coronary vasculopathy after cardiac transplantation.
Densem CG; Hutchinson IV; Yonan N; Brooks NH
J Heart Lung Transplant; 2001 Dec; 20(12):1265-73. PubMed ID: 11744409
[TBL] [Abstract][Full Text] [Related]
6. The transforming growth factor-beta1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation.
Holweg CT; Baan CC; Balk AH; Niesters HG; Maat AP; Mulder PM; Weimar W
Transplantation; 2001 May; 71(10):1463-7. PubMed ID: 11391236
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 polymorphism: a genetic risk factor for cardiac transplant related coronary vasculopathy?
Densem CG; Ray M; Hutchinson IV; Yonan N; Brooks NH
J Heart Lung Transplant; 2005 May; 24(5):559-65. PubMed ID: 15896753
[TBL] [Abstract][Full Text] [Related]
8. Influence of IFN-gamma polymorphism on the development of coronary vasculopathy after cardiac transplantation.
Densem CG; Hutchinson IV; Yonan N; Brooks NH
Ann Thorac Surg; 2004 Mar; 77(3):875-80. PubMed ID: 14992891
[TBL] [Abstract][Full Text] [Related]
9. Influence of interleukin-10 polymorphism on the development of coronary vasculopathy following cardiac transplantation.
Densem CG; Hutchinson IV; Yonan N; Brooks NH
Transpl Immunol; 2003; 11(2):223-8. PubMed ID: 12799207
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta polymorphisms and cardiac allograft rejection.
Benza RL; Coffey CS; Pekarek DM; Barchue JP; Tallaj JA; Passineau MJ; Grenett HE
J Heart Lung Transplant; 2009 Oct; 28(10):1057-62. PubMed ID: 19782287
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta (TGF-beta1) genotype and lung allograft fibrosis.
El-Gamel A; Awad MR; Hasleton PS; Yonan NA; Hutchinson JA; Campbell CS; Rahman AH; Deiraniya AK; Sinnott PJ; Hutchinson IV
J Heart Lung Transplant; 1999 Jun; 18(6):517-23. PubMed ID: 10395349
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy.
Tambur AR; Pamboukian S; Costanzo MR; Heroux A
J Heart Lung Transplant; 2006 Jun; 25(6):690-8. PubMed ID: 16730575
[TBL] [Abstract][Full Text] [Related]
13. Haptoglobin phenotype correlates with development of cardiac transplant vasculopathy.
Densem CG; Wassel J; Cooper A; Yonan N; Brooks NH; Keevil B
J Heart Lung Transplant; 2004 Jan; 23(1):43-9. PubMed ID: 14734126
[TBL] [Abstract][Full Text] [Related]
14. The effect of recipient cytokine gene polymorphism on cardiac transplantation outcome.
Gourley IS; Denofrio D; Rand W; Desai S; Loh E; Kamoun M
Hum Immunol; 2004 Mar; 65(3):248-54. PubMed ID: 15041164
[TBL] [Abstract][Full Text] [Related]
15. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
[TBL] [Abstract][Full Text] [Related]
16. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
17. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 gene polymorphism in renal transplant recipients.
Chow KM; Szeto CC; Poon P; Lau WY; Lai FM; Li PK
Ren Fail; 2005; 27(6):671-5. PubMed ID: 16350816
[TBL] [Abstract][Full Text] [Related]
19. Genetic association of interleukin-2, interleukin-4, interleukin-6, transforming growth factor-β, tumour necrosis factor-α and blood concentrations of calcineurin inhibitors in Turkish renal transplant patients.
Seyhun Y; Ciftci HS; Kekik C; Karadeniz MS; Tefik T; Nane I; Turkmen A; Oguz FS; Aydin F
Int J Immunogenet; 2015 Jun; 42(3):147-60. PubMed ID: 25817300
[TBL] [Abstract][Full Text] [Related]
20. Significance of the tissue kallikrein promoter and transforming growth factor-beta1 polymorphisms with renal progression in children with vesicoureteral reflux.
Lee-Chen GJ; Liu KP; Lai YC; Juang HS; Huang SY; Lin CY
Kidney Int; 2004 Apr; 65(4):1467-72. PubMed ID: 15086490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
